Recent developments in age-related macular degeneration: a review | CIA
Epimacular brachytherapy for wet AMD: current perspectives | OPTH
Update on clinical trials in dry Age-related macular degeneration Taskintuna I, Elsayed MA, Schatz P - Middle East Afr J Ophthalmol
JCM | Free Full-Text | Trends of Stem Cell Therapies in Age-Related Macular Degeneration
Gene therapy in AMD: Promises and challenges
New medicines targeting age-related macular degeneration, Industry news, Media Center, NovaMedica
Retinal Physician - Preclinical and Phase 1 Drugs in Development for Dry AMD: An Overview
Stealth stumbles as AMD joins list of clinical trial flops
Treatments for dry age-related macular degeneration: therapeutic avenues, clinical trials and future directions | British Journal of Ophthalmology
LumiThera unveils LIGHTSITE III clinical trial data for improving vision in patients with dry age-related macular degeneration
Global Burden of Dry Age-Related Macular Degeneration: A Targeted Literature Review - Clinical Therapeutics
Therapeutic Approaches with Intravitreal Injections in Geographic Atrophy Secondary to Age-Related Macular Degeneration: Current Drugs and Potential Molecules[v1] | Preprints
National Retina Institute | Current Clinical Trials | Maryland
C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration - Ophthalmology
HAWK and HARRIER: Phase 3, Multicenter, Randomized, Double-Masked Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration - Ophthalmology
Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci
Phase III Trials in Wet AMD—What's Next?
Dry AMD Research Moves Ahead: Clinical Trials and New Leads - American Academy of Ophthalmology
Overview of clinical trials for dry age-related macular degeneration Cheng WS, Lu DW, Chiang CH, Chang CJ - J Med Sci